Ansell’s strategic focus is on growing market share in niche markets across industrial and healthcare settings. We think this strategy is appropriate, given a less competitive environment in niche markets, where product innovation and regulatory requirements raise barriers to entry, and an ability to achieve better margins from these sales.
Expansion in clean room and surgical, a niche where Ansell’s products are more differentiated, earns materially higher margins than its other businesses, supporting group margin growth.
Cost pressures such as tariffs and supply chain disruptions weigh on operations, without certainty that price pass-throughs will succeed.
|
Metric
|
ANN
|
RKT
|
BDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.24 | 20.37 | 15.30 |
Price/Book Value | 2.23 | 6.20 | 2.22 |
Price/Sales | 2.11 | 2.64 | 2.81 |
Price/Cash Flow | 13.17 | 14.81 | 15.01 |
|
Metric
|
ANN
|
RKT
|
BDX
|
|---|---|---|---|
Quick Ratio | 1.14 | 0.38 | 0.36 |
Current Ratio | 2.30 | 0.59 | 0.94 |
Interest Coverage | 7.09 | 8.84 | 3.53 |
|
Metric
|
ANN
|
RKT
|
BDX
|
|---|---|---|---|
Return on Assets (Normalized) | 6.41% | 9.05% | 4.97% |
Return on Equity (Normalized) | 10.75% | 33.99% | 10.63% |
Return on Invested Capital (Normalized) | 8.69% | 15.92% | 7.26% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|mdT><sby | LOCK|XJ | $160B | |||
| Becton Dickinson & Co
BDX
| LOCK|N!> | LOCK|&f&w | $54B | |||
| ResMed Inc
RMD
| LOCK|&ry%Z?>q | LOCK|#zGL | $36B | |||
| Alcon Inc
ALC
| LOCK|djLH?M | LOCK|%D%w | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|try^gZ | LOCK|H^W! | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|&&Xx$>R | LOCK|B< | $28B | |||
| Solventum Corp
SOLV
| LOCK|K<Xtj> | LOCK|t$ | $15B | |||
| Baxter International Inc
BAX
| LOCK|tmW | LOCK|zj?%f | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|<l@&@W | LOCK|Cshv | $12B | |||
| Repligen Corp
RGEN
| LOCK|BG@Y@?g | LOCK|cSzC | $11B |
United States